Patent classifications
C07D263/50
MYST family histone acetyltransferase inhibitors
The present disclosure provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
N-myristoyl transferase inhibitors
The present invention relates to N-heterocyclic sulphonamide compounds, in particular pyrazole sulphonamide compounds, and their use as N-myristoyl transferase inhibitors.
N-myristoyl transferase inhibitors
The present invention relates to N-heterocyclic sulphonamide compounds, in particular pyrazole sulphonamide compounds, and their use as N-myristoyl transferase inhibitors.
NOVEL SULFONYLAMINOBENZAMIDE COMPOUNDS AS ANTHELMINTICS
The present invention relates to a new compound of formula (I) wherein the variables have the meaning as indicated in the claims; or an enantiomer or salt thereof. The compounds of formula (I) are useful in the control of parasites, in particular endoparasites, in and on vertebrates.
##STR00001##
NOVEL SULFONYLAMINOBENZAMIDE COMPOUNDS AS ANTHELMINTICS
The present invention relates to a new compound of formula (I) wherein the variables have the meaning as indicated in the claims; or an enantiomer or salt thereof. The compounds of formula (I) are useful in the control of parasites, in particular endoparasites, in and on vertebrates.
##STR00001##
COMPOUNDS CONTAINING A SULFONIC GROUP AS KAT INHIBITORS
The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
##STR00001##
COMPOUNDS CONTAINING A SULFONIC GROUP AS KAT INHIBITORS
The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
##STR00001##
Benzenesulfonamide compouds and their use as therapeutic agents
- Jean-Christophe Andrez ,
- David Earl Bogucki ,
- Kristen Nicole Burford ,
- Sultan Chowdhury ,
- Charles Jay Cohen ,
- Shannon Marie Decker ,
- Christoph Martin Dehnhardt ,
- Robert Joseph Devita ,
- James Roy Empfield ,
- Thilo Focken ,
- Michael Edward Grimwood ,
- Syed Abid Hasan ,
- Qi Jia ,
- James Philip Johnson, Jr. ,
- Michael Scott Wilson ,
- Alla Yurevna Zenova
This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy and/or epileptic seizure disorders.
Benzenesulfonamide compouds and their use as therapeutic agents
- Jean-Christophe Andrez ,
- David Earl Bogucki ,
- Kristen Nicole Burford ,
- Sultan Chowdhury ,
- Charles Jay Cohen ,
- Shannon Marie Decker ,
- Christoph Martin Dehnhardt ,
- Robert Joseph Devita ,
- James Roy Empfield ,
- Thilo Focken ,
- Michael Edward Grimwood ,
- Syed Abid Hasan ,
- Qi Jia ,
- James Philip Johnson, Jr. ,
- Michael Scott Wilson ,
- Alla Yurevna Zenova
This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy and/or epileptic seizure disorders.
BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
- Jean-Christophe Andrez ,
- David Earl Bogucki ,
- Kristen Nicole Burford ,
- Sultan Chowdhury ,
- Charles Jay Cohen ,
- Shannon Marie Decker ,
- Christoph Martin Dehnhardt ,
- Robert Joseph Devita ,
- James Roy Empfield ,
- Thilo Focken ,
- Michael Edward Grimwood ,
- Syed Abid Hasan ,
- Qi Jia ,
- James Philip Johnson, Jr. ,
- Michael Scott Wilson ,
- Alla Yurevna Zenova
This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy and/or epileptic seizure disorders.